GUD HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.36 AUD | -2.72% |
|
-1.43% | -13.67% |
| Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
| Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Valuation
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 865.7 | 997.9 | 1,129 | 1,126 | 1,243 | 1,460 | - | - |
| Enterprise Value (EV) 1 | 998.4 | 1,140 | 1,360 | 1,593 | 1,645 | 1,827 | 1,787 | 1,732 |
| P/E ratio | 14.6 x | 23 x | 18 x | 35.2 x | 12.8 x | 14.6 x | 12.6 x | 11.6 x |
| Yield | 5.59% | 3.21% | 4.75% | 4.88% | 4.42% | 4.04% | 4.67% | 5.05% |
| Capitalization / Revenue | 1.99 x | 2.28 x | 2.03 x | 1.35 x | 1.2 x | 1.47 x | 1.4 x | 1.33 x |
| EV / Revenue | 2.3 x | 2.6 x | 2.44 x | 1.91 x | 1.59 x | 1.84 x | 1.71 x | 1.58 x |
| EV / EBITDA | 10.8 x | 11.9 x | 11.4 x | 8.53 x | 7.42 x | 8.27 x | 7.37 x | 6.69 x |
| EV / FCF | 26.1 x | 19.3 x | 19.9 x | 20.3 x | 8.49 x | 17.6 x | 14.6 x | 12.8 x |
| FCF Yield | 3.83% | 5.18% | 5.03% | 4.92% | 11.8% | 5.69% | 6.85% | 7.78% |
| Price to Book | 3.11 x | 3.63 x | 2.9 x | 1.94 x | 1.4 x | 1.57 x | 1.48 x | 1.4 x |
| Nbr of stocks (in thousands) | 86,486 | 86,701 | 94,181 | 140,895 | 140,895 | 140,895 | - | - |
| Reference price 2 | 10.01 | 11.51 | 11.99 | 7.990 | 8.820 | 10.36 | 10.36 | 10.36 |
| Announcement Date | 7/25/19 | 7/27/20 | 8/3/21 | 8/14/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 434.1 | 438 | 557 | 835.5 | 1,037 | 993.1 | 1,046 | 1,096 |
| EBITDA 1 | 92.2 | 95.72 | 119.8 | 186.8 | 221.8 | 220.9 | 242.6 | 259 |
| EBIT 1 | 88.9 | 80.72 | 101.2 | 149.5 | 166 | 172.7 | 193.8 | 209 |
| Operating Margin | 20.48% | 18.43% | 18.17% | 17.89% | 16.01% | 17.39% | 18.52% | 19.07% |
| Earnings before Tax (EBT) 1 | 80.24 | 63.65 | 86.97 | 59.54 | 131.7 | 146.5 | 165.9 | 181.3 |
| Net income 1 | 59.56 | 43.68 | 60.97 | 27.34 | 97.92 | 100.7 | 116.8 | 126.9 |
| Net margin | 13.72% | 9.97% | 10.95% | 3.27% | 9.44% | 10.14% | 11.16% | 11.58% |
| EPS 2 | 0.6840 | 0.5000 | 0.6650 | 0.2270 | 0.6890 | 0.7114 | 0.8250 | 0.8949 |
| Free Cash Flow 1 | 38.24 | 59.02 | 68.4 | 78.29 | 193.7 | 104 | 122.4 | 134.8 |
| FCF margin | 8.81% | 13.48% | 12.28% | 9.37% | 18.68% | 10.48% | 11.7% | 12.3% |
| FCF Conversion (EBITDA) | 41.47% | 61.66% | 57.09% | 41.91% | 87.35% | 47.1% | 50.45% | 52.05% |
| FCF Conversion (Net income) | 64.2% | 135.14% | 112.19% | 286.37% | 197.86% | 103.28% | 104.78% | 106.28% |
| Dividend per Share 2 | 0.5600 | 0.3700 | 0.5700 | 0.3900 | 0.3900 | 0.4190 | 0.4835 | 0.5233 |
| Announcement Date | 7/25/19 | 7/27/20 | 8/3/21 | 8/14/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 227.1 | 210.9 | 251.5 | 305.5 | 332 | 492.6 | 488.9 | - | - |
| EBITDA | - | - | - | - | - | 112 | - | - | - |
| EBIT | - | - | - | 48.9 | 59 | - | - | - | - |
| Operating Margin | - | - | - | 16.01% | 17.77% | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| EPS | 0.3050 | - | 0.3420 | - | - | - | - | 0.4200 | 0.4300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 1/30/20 | 7/27/20 | 2/10/21 | 8/3/21 | 2/8/22 | 2/13/24 | - | - | - |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 133 | 142 | 231 | 467 | 402 | 368 | 327 | 273 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.439 x | 1.485 x | 1.927 x | 2.5 x | 1.813 x | 1.664 x | 1.349 x | 1.053 x |
| Free Cash Flow 1 | 38.2 | 59 | 68.4 | 78.3 | 194 | 104 | 122 | 135 |
| ROE (net income / shareholders' equity) | 22.4% | 17.4% | 19.3% | 4.42% | 11.9% | 11.8% | 13% | 13.4% |
| ROA (Net income/ Total Assets) | 11.9% | 8.04% | 8.75% | 6.58% | 5.64% | 6.28% | 7.37% | 7.9% |
| Assets 1 | 502.1 | 543.3 | 696.8 | 415.3 | 1,736 | 1,604 | 1,585 | 1,605 |
| Book Value Per Share 2 | 3.220 | 3.170 | 4.130 | 4.130 | 6.310 | 6.600 | 6.980 | 7.420 |
| Cash Flow per Share 2 | 0.5100 | 0.7500 | 0.8100 | 0.7600 | 1.450 | 0.7800 | 0.9400 | 1.000 |
| Capex 1 | 6.29 | 6.49 | 5.96 | 13.7 | 12.4 | 18.6 | 18 | 18.6 |
| Capex / Sales | 1.45% | 1.48% | 1.07% | 1.64% | 1.2% | 1.88% | 1.72% | 1.7% |
| Announcement Date | 7/25/19 | 7/27/20 | 8/3/21 | 8/14/22 | 8/14/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
10.36
AUD
Average target price
13.16
AUD
Spread / Average Target
+27.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.67% | 952M | |
| +29.62% | 50.98B | |
| +25.77% | 20.39B | |
| -20.63% | 19.42B | |
| +31.67% | 17.27B | |
| +1.48% | 15.84B | |
| -18.75% | 13.35B | |
| +31.97% | 11.74B | |
| +28.58% | 10.66B | |
| +30.12% | 10.21B |
- Stock Market
- Equities
- GUD Stock
- Financials GUD Holdings Limited
